(Q34387327)

1 August 2017

1 reference

title

Treating the core features of autism: are we there yet? (English)

1 reference

1 August 2017

0 references

James W Bodfish

1

1 reference

1 August 2017

publication date

1 January 2004

1 reference

Mental Retardation and Developmental Disabilities Research Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

318-326

1 reference

Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Reciprocal social behavior in children with and without pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

The autistic child in adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Positive reinforcement and behavioral deficits of autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Language acquisition and communicative behavior in autism: toward an understanding of the "whole" of it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Placebo effects in autism: lessons from secretin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

Effect of Treatment Structure on Development in Autistic Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

The effects of mands and models on the speech of unresponsive language-delayed preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20045

21 January 2018

Identifiers

DOI

10.1002/MRDD.20045

1 reference

1 August 2017

1 reference